Technology | 2016.04.13
Certara Launches the SIVA Toolkit 2.0 to Improve Analysis of In Vitro Drug Development Data
PRINCETON, N.J.--(BUSINESS WIRE)--Certara, the global biosimulation technology-enabled drug development company, today launched the SIVA Toolkit 2.0 to assist drug development researchers with analyzing complex in vitro ADME studies.
For more information, please visit
http://www.businesswire.com/news/home/20[...]A-Toolkit-2.0-Improve-Analysis
